Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$68.86 - $83.34 $29,885 - $36,169
-434 Closed
0 $0
Q4 2020

Feb 26, 2021

BUY
$96.85 - $148.25 $42,032 - $64,340
434 New
434 $43,000
Q3 2020

Nov 13, 2020

SELL
$122.47 - $213.56 $48,498 - $84,569
-396 Closed
0 $0
Q4 2019

Mar 03, 2020

BUY
$146.12 - $215.82 $57,863 - $85,464
396 New
396 $82,000

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.9B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Rmr Wealth Builders Portfolio

Follow Rmr Wealth Builders and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rmr Wealth Builders, based on Form 13F filings with the SEC.

News

Stay updated on Rmr Wealth Builders with notifications on news.